Literature DB >> 10641728

Expression of superoxide dismutases, catalase, and glutathione peroxidase in glioma cells.

W Zhong1, T Yan, R Lim, L W Oberley.   

Abstract

Four primary antioxidant enzymes were measured in both human and rat glioma cells. Both manganese-containing superoxide dismutase (MnSOD) and copper-zinc-containing superoxide dismutase (CuZnSOD) activities varied greatly among the different glioma cell lines. MnSOD was generally higher in human glioma cells than in rat glioma cells and relatively higher than in other tumor types. High levels of MnSOD in human glioma cells were due to the high levels of expression of MnSOD mRNA and protein. Heterogeneous expression of MnSOD was present in individual glioma cell lines and may be due to subpopulations or cells at different differentiation stages. Less difference in CuZnSOD, catalase, or glutathione peroxide was found between human and rat glioma cells. The human glioma cell lines showed large differences in sensitivity to the glutathione modulating drugs 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) and buthionine sulfoximine (BSO). A good correlation was found between sensitivity to BCNU and the activities of catalase in these cell lines. Only one cell line was sensitive to BSO and this line had low CuZnSOD activity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10641728     DOI: 10.1016/s0891-5849(99)00181-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  20 in total

1.  Distinct functions of CCAAT enhancer-binding protein isoforms in the regulation of manganese superoxide dismutase during interleukin-1beta stimulation.

Authors:  Xiaolei Qiu; Kimberly J Aiken; Ann L Chokas; Dawn E Beachy; Harry S Nick
Journal:  J Biol Chem       Date:  2008-06-17       Impact factor: 5.157

Review 2.  Manganese superoxide dismutase (Sod2) and redox-control of signaling events that drive metastasis.

Authors:  Nadine Hempel; Pauline M Carrico; J Andres Melendez
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

3.  Short-echo three-dimensional H-1 MR spectroscopic imaging of patients with glioma at 7 Tesla for characterization of differences in metabolite levels.

Authors:  Yan Li; Peder Larson; Albert P Chen; Janine M Lupo; Eugene Ozhinsky; Douglas Kelley; Susan M Chang; Sarah J Nelson
Journal:  J Magn Reson Imaging       Date:  2014-06-17       Impact factor: 4.813

4.  Aldehydic lipid peroxidation products in human brain astrocytomas.

Authors:  Alicja Zajdel; Adam Wilczok; Jerzy Slowinski; Joanna Orchel; Urszula Mazurek
Journal:  J Neurooncol       Date:  2007-05-09       Impact factor: 4.130

5.  Inhibitors of hydroperoxide metabolism enhance ascorbate-induced cytotoxicity.

Authors:  K E Olney; J Du; T J van 't Erve; J R Witmer; Z A Sibenaller; B A Wagner; G R Buettner; J J Cullen
Journal:  Free Radic Res       Date:  2013-01-09

6.  Enhancing the antitumor activity of adriamycin and ionizing radiation.

Authors:  Wenqing Sun; Amanda L Kalen; Brian J Smith; Joseph J Cullen; Larry W Oberley
Journal:  Cancer Res       Date:  2009-04-28       Impact factor: 12.701

7.  Total dietary antioxidant index and survival in patients with glioblastoma multiforme.

Authors:  Dora Il'yasova; Jennifer E Marcello; Lucie McCoy; Terri Rice; Margaret Wrensch
Journal:  Cancer Causes Control       Date:  2009-04-12       Impact factor: 2.506

8.  Decreasing peroxiredoxin II expression decreases glutathione, alters cell cycle distribution, and sensitizes glioma cells to ionizing radiation and H(2)O(2).

Authors:  Pameeka S Smith-Pearson; Mitra Kooshki; Douglas R Spitz; Leslie B Poole; Weiling Zhao; Mike E Robbins
Journal:  Free Radic Biol Med       Date:  2008-07-27       Impact factor: 7.376

9.  Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischemia.

Authors:  Amina A Qutub; Aleksander S Popel
Journal:  Mol Cell Biol       Date:  2008-06-16       Impact factor: 4.272

10.  Differential activation of catalase expression and activity by PPAR agonists: implications for astrocyte protection in anti-glioma therapy.

Authors:  Nicholas K H Khoo; Sachin Hebbar; Weiling Zhao; Steven A Moore; Frederick E Domann; Mike E Robbins
Journal:  Redox Biol       Date:  2013-01-26       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.